MedPath

Omiganan

Generic Name
Omiganan
Drug Type
Small Molecule
Chemical Formula
C90H127N27O12
CAS Number
204248-78-2
Unique Ingredient Identifier
618SLL9VBS

Overview

Omiganan has been investigated for the treatment of Mupirocin-resistant MRSA skin infections.

Background

Omiganan has been investigated for the treatment of Mupirocin-resistant MRSA skin infections.

Indication

Investigated for use/treatment in bacterial infection and rosacea.

Associated Conditions

No associated conditions information available.

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath